Liver cirrhosis, occurring due to chronic liver disease or CLD, damages the liver structure and interferes with its normal functions. Due to the progressive nature of the disease, the damage continues to spread. The CLD treatment focuses on halting this progression and managing the symptoms. However, it does not restore the deteriorated tissue, and the liver keeps functioning at a reduced capacity.
For years, scientists have been working on solutions to repair the damage. Among these solutions, Stem Cell Treatment for Liver Damage has achieved promising results. By restoring organ structure, this therapy improves its function rather than only sustaining it. This therapy is a step further than conventional treatment by restoring the original tissue structure and function. This article delves into this regenerative therapy for liver cirrhosis and its benefits.
Understanding CLD and Liver Cirrhosis
Chronic liver disease (CLD) is a chronic and progressive disease. It results from different causes, such as excessive alcohol consumption, hepatitis, genetic disorder, etc. CLD typically begins with any injury and its consequent repair. However, repetitive injuries dysregulate the repair process, replacing healthy tissue with scar tissue. This stage is known as fibrosis, which is still reversible. But as the scar tissue spreads, damage enters the irreversible cirrhosis stage.
The Chronic Liver Disease (CLD) Treatment prevents the spread of scar tissue and the resulting symptoms. Advanced stages or extensive liver damage necessitate the transplant of a healthy liver. However, a transplant requires long waiting times due to the scarcity of donors. Additionally, issues such as cost factors and risk of future complications are associated with transplant. Therefore, a therapy that can overcome this hurdle is much-awaited.
Stem Cell Treatment for Liver Damage
The stem cell treatment relies on stem cells. They can form different types of cells. This property is beneficial for damage repair, as stem cells can replenish lost cells with healthy tissue cells to reinstate the original structure and function. Among the many types of stem cells, mesenchymal stem cells (MSCs) have become the forefront of this therapy.
MSCs are readily available from different sources in abundant amounts for transplant. Harvesting them from the patient and the donor is a minimally invasive process. Moreover, umbilical cord-derived MSCs show even lower risk of rejection and higher regenerative potential than any other sources of MSC. Thus, clinical trials often employ three different sources of MSCs- umbilical cord, bone marrow, and adipose tissue. Below are some benefits of stem cells for liver cirrhosis.
Regenerative Therapy for Liver Cirrhosis: Mechanism of Action
The therapeutic effects of MSCs arise from more than one mechanism. These include:
- Replenish Cells: MSCs stimulate the progenitors present in the liver to create more healthy cells to reinstate its structure. Moreover, MSCs also protect the surviving cells from further harm, thereby delaying and/or halting disease progression.
- Anti-fibrotic Effect: MSCs also induce enzymes that break down the scar tissue and reduce scar size. Thus, these cells promote the formation of healthy tissue.
Regenerative Therapy for Liver Cirrhosis Mechanism
- Combat Inflammation: Inflammation is the key pathway behind scar tissue formation and its subsequent spread. Inflammation, along with free oxygen radicals, worsens the damage. MSCs increase the levels of anti-inflammatory cytokines to mitigate inflammation and prevent further spread of damage.
- Alter Immune Response: Immune cells play a vital role in repair. However, the dysregulation of the repair process heightens the immune activity at the repair site, which is harmful to the tissue. MSCs shift this immune response in favor of healing by stimulating appropriate immune cells.
These combined effects act on different aspects of the disease and its resulting damage.
Therefore. MSCs not only perform damage repair but also suppress the underlying disease mechanisms. It not only slows disease progression but can also lead to structural and functional improvements in the liver.
Advancement Over Traditional Treatments
Conventional CLD treatment includes medications to treat the underlying cause of the disease. However, they cannot regenerate the tissue to return to its original functional capacity. The effects of therapy become limited at advanced stages. In comparison to the conventional approach, stem cells demonstrate a clear advantage.
Traditional Chronic Liver Disease (CLD) Treatment alleviates symptoms and prevent further deterioration of the tissue. On the other hand, stem cells promotes the regeneration of the tissue. Unlike standard care, stem cells can slow or even reverse scar tissue buildup. Stem cells can also suppress pathways that harm the tissue at a cellular level. Therefore, stem cell therapy has a more holistic approach, which mitigates disease and repairs tissue. While conventional methods offer only temporary relief, the impact of stem cells has longer sustainability. Together, these differences highlight the transformative potential of the regenerative therapy.
Clinical Evidence Supporting Stem Cell Therapy
A growing number of clinical trials have showed the therapeutic impact of stem cell therapy in CLD patients. Reported outcomes include:
- Improved liver function tests, with reductions in liver enzymes (ALT, AST) and bilirubin levels, signaling enhanced liver health.
- Partial reversal of fibrosis
- Symptom relief, such as fatigue and jaundice.
- Extended survival.
Adverse effects of stem cell treatment are generally mild and transient and include temporary fever or discomfort at the injection site.
Stem Cell Treatment for Liver Cirrhosis in India
Accessibility remains a key factor in stem cell treatment. While traditional treatments are widely available, stem cell therapy is still expanding and may be limited to specialized centers. But India is gradually rising as a hub of regenerative medicine. A notable case was seen in Mumbai. Infusion of stem cells reversed cirrhosis in a 61-year-old woman. The imaging results show normal parameters within three months. Such cases have inspired global interest in regenerative approaches as viable alternatives to transplantation.
Advancells is a vital for accessing stem cell therapy. The company conducts research and manufactures high-quality stem cells for therapies. Its scientific team rigorously processes the cells to ensure their quality and consistency. The company follows regulatory guidelines and ethical conduct as per the norms, showing its commitment to standards.
Patient Success Stories
Key Takeaways
Liver regeneration is the most promising avenue for CLD treatment. However, traditional therapies fail to offer these therapeutic effects. In turn, patients often rely on a liver transplant or living with low organ capacity. In this area, stem cell treatment for liver damage has stood out with its regenerative ability. It promotes liver regeneration, restoring some of the organ architecture. Thus, the therapy improves function and enhances survival, leading to improved quality of life.
India has created an ecosystem that promotes such regenerative therapies. The country is set to redefine CLD treatment and management. Advancells is improving the accessibility of the regenerative therapy for liver cirrhosis by its quality-assured stem cells and extensive research. These cells are transforming a terminal condition into a treatable disorder, offering hope to many.
FAQ’s
Q- What types of stem cells are used for stem cell treatment?
Mesenchymal stem cells (MSCs) are most widely used for treating cirrhosis. They are available from bone marrow, adipose (fat) tissue, and umbilical cord due to their high versatility and low immunogenicity.
Q- Is stem cell therapy for liver cirrhosis safe?
Clinical trials have repeatedly shown that mesenchymal stem cell therapy is generally safe when performed under medical supervision, with very few serious side effects reported.Most risks relate to mild infusion reactions or transient symptoms.
Q- What improvements result from stem cell therapy for liver damage?
Patients treated with MSC therapy for liver cirrhosis report better liver function, lowered markers of liver injury, and improved clinical scores in many studies. Commonly seen benefits include reduced ascites, enhanced wellness, and alleviation of symptoms such as jaundice or fatigue.
Q- How long do results last?
Clinical studies suggest improvements in liver function are often sustained for several months after MSC infusion. However, the time period varies with individuals and their condition. Long-term studies are still ongoing, with some research suggesting the effects may last up to a year or more, but durability for several years is still being investigated.
Recent Comments